Winway Health Desk
Novartis plans to seek approval for CAR-T in slow-growing lymphoma after...
Fresh off the heels of the Food and Drug Administration approval of the third CAR-T cell therapy, a company that markets one of the...
J&J in $1B supply pact with federal government for one-shot Covid-19...
Federal authorities will pay up to $1 billion for supplies of vaccine against the virus that causes Covid-19 from a company that has become...
Attention digital health startups: MedCity’s next pitch competition is looking for...
MedCity News is gearing up for our INVEST Digital Health Virtual event, Sep 21-25. That week, we are hosting four separate pitch contests to spotlight...
Congress, states hold the keys to telehealth expansion
An executive order signed Monday directed a swath of federal agencies to expand telehealth services after the pandemic ends. But at this point, much...
Has telehealth hit the high watermark?
In the immediate aftermath of the COVID-19 pandemic, health systems saw dramatic spikes in virtual visits and telehealth adoption in the patient population. The...
EU regulators to launch in-depth investigation of Google-Fitbit merger
The European Commission opened an in-depth investigation of Google’s proposed acquisition of Fitbit, it announced on Tuesday. Regulators said they were concerned that the...
Strategies For Reopening During The COVID-19 Pandemic
Across the country, we are seeing numerous changes at healthcare facilities as they reopen for elective and non-critical care while still addressing potential surge...
Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls
After global recalls of heartburn medicine Zantac and an FDA ban, the Department of Justice is investigating Sanofi and GlaxoSmithKline for possible violations of the...
Merck, Hanmi sign $870M deal for NASH drug
A Korean drugmaker may receive more than $800 million from U.S. drugmaker Merck under a licensing agreement for a drug developed for nonalcoholic steatohepatitis.
Kenilworth,...
Did insiders trade illegally ahead of Kodak’s manufacturing deal? Sen. Warren...
Amid the COVID-19 crisis, the U.S. government has committed billions of taxpayer dollars to companies working on tests, therapeutics and vaccines. One unlikely company to receive...
